• Publications
  • Influence
Clinical oncological applications of Positron Emission Tomography (PET) using fluorine-18-fluoro-2-deoxy-D-glucose.
Although about 90% of clinical investigations in oncology are performed using [18F]FDG as the tracer, radiopharmaceutical research is continuously developing new and more specific tumor targeting agents, whose efficacy is being explored more and more in the wide scale. Expand
High-performance liquid chromatographic determination of the magnetic resonance imaging contrast agent Gadocoletate ion in human plasma, urine and faeces.
The results of dedicated studies showed that Gadocoletate ion is stable in human plasma samples when stored at +4 degrees C for up to 30 days and at -80 degrees CFor up to 90 days. Expand
Evaluation of effective renal plasma flow with I-127 ortho-iodohippurate and I-123 ortho-iodohippurate in rabbits.
The results obtained in this study demonstrate the feasibility of the new system for evaluating ERPF, provided that a compound with adequate glomerular filtration and tubular secretion properties is employed. Expand